APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Nausea and Vomiting Healthcare Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Nausea and Vomiting Healthcare Device Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchAnti-Nausea and Vomiting Healthcare Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Nausea and Vomiting Healthcare Device Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Anti-Nausea and Vomiting Healthcare Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Nausea and Vomiting Healthcare Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Nausea and Vomiting Healthcare Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anti-Nausea and Vomiting Healthcare Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Nausea and Vomiting Healthcare Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Nausea and Vomiting Healthcare Device market include Blisslets, Dramamine(Prestige Consumer Healthcare), EmeTerm (WAT Medical), GRAVOL, MotionCure (Sidis Labs), NoMo, Psi Bands, Quease EASE (Soothing Scents) and Reliefband, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Nausea and Vomiting Healthcare Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Nausea and Vomiting Healthcare Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Nausea and Vomiting Healthcare Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Nausea and Vomiting Healthcare Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Nausea and Vomiting Healthcare Device Segment by Company

Blisslets

Dramamine(Prestige Consumer Healthcare)

EmeTerm (WAT Medical)

GRAVOL

MotionCure (Sidis Labs)

NoMo

Psi Bands

Quease EASE (Soothing Scents)

Reliefband

Sea-Bands

Toulifly

Walgreens

Anti-Nausea and Vomiting Healthcare Device Segment by Type

Inhaler

Wrist Band

Food

Others

Anti-Nausea and Vomiting Healthcare Device Segment by Application

For Children

For Pregnant

For other people with motion sickness

Anti-Nausea and Vomiting Healthcare Device Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anti-Nausea and Vomiting Healthcare Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-Nausea and Vomiting Healthcare Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Nausea and Vomiting Healthcare Device significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Nausea and Vomiting Healthcare Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Nausea and Vomiting Healthcare Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Nausea and Vomiting Healthcare Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Nausea and Vomiting Healthcare Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Nausea and Vomiting Healthcare Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Nausea and Vomiting Healthcare Device industry.

Chapter 3: Detailed analysis of Anti-Nausea and Vomiting Healthcare Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-Nausea and Vomiting Healthcare Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-Nausea and Vomiting Healthcare Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Nausea and Vomiting Healthcare Device Industry Trends Table 2. Anti-Nausea and Vomiting Healthcare Device Industry Drivers Table 3. Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges Table 4. Anti-Nausea and Vomiting Healthcare Device Industry Restraints Table 5. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Nausea and Vomiting Healthcare Device Revenue Share by Company (2021-2026) Table 7. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Company (2021-2026) Table 9. Global Anti-Nausea and Vomiting Healthcare Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-Nausea and Vomiting Healthcare Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-Nausea and Vomiting Healthcare Device Key Company Manufacturing Base & Headquarters Table 12. Global Anti-Nausea and Vomiting Healthcare Device Company, Product Type & Application Table 13. Global Anti-Nausea and Vomiting Healthcare Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Nausea and Vomiting Healthcare Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inhaler Table 18. Significant Companies of Wrist Band Table 19. Significant Companies of Food Table 20. Significant Companies of Others Table 21. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Type (2021-2026) Table 25. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Type (2027-2032) Table 26. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type (2021-2026) Table 30. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type (2027-2032) Table 31. Significant Companies of For Children Table 32. Significant Companies of For Pregnant Table 33. Significant Companies of For other people with motion sickness Table 34. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Application (2021-2026) Table 38. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Application (2027-2032) Table 39. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application (2021-2026) Table 43. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application (2027-2032) Table 44. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026) & (K Units) Table 46. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2021-2026) Table 47. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032) & (K Units) Table 48. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2027-2032) Table 49. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Region (2021-2026) Table 52. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Region (2027-2032) Table 54. Global Anti-Nausea and Vomiting Healthcare Device Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Anti-Nausea and Vomiting Healthcare Device Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 59. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 60. Global Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 61. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2027-2032) Table 62. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Market Share by Country (2021-2026) Table 64. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Market Share by Country (2027-2032) Table 66. Blisslets Company Information Table 67. Blisslets Business Overview Table 68. Blisslets Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 70. Blisslets Recent Development Table 71. Dramamine(Prestige Consumer Healthcare) Company Information Table 72. Dramamine(Prestige Consumer Healthcare) Business Overview Table 73. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 75. Dramamine(Prestige Consumer Healthcare) Recent Development Table 76. EmeTerm (WAT Medical) Company Information Table 77. EmeTerm (WAT Medical) Business Overview Table 78. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 80. EmeTerm (WAT Medical) Recent Development Table 81. GRAVOL Company Information Table 82. GRAVOL Business Overview Table 83. GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 85. GRAVOL Recent Development Table 86. MotionCure (Sidis Labs) Company Information Table 87. MotionCure (Sidis Labs) Business Overview Table 88. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 90. MotionCure (Sidis Labs) Recent Development Table 91. NoMo Company Information Table 92. NoMo Business Overview Table 93. NoMo Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 95. NoMo Recent Development Table 96. Psi Bands Company Information Table 97. Psi Bands Business Overview Table 98. Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 100. Psi Bands Recent Development Table 101. Quease EASE (Soothing Scents) Company Information Table 102. Quease EASE (Soothing Scents) Business Overview Table 103. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 105. Quease EASE (Soothing Scents) Recent Development Table 106. Reliefband Company Information Table 107. Reliefband Business Overview Table 108. Reliefband Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 110. Reliefband Recent Development Table 111. Sea-Bands Company Information Table 112. Sea-Bands Business Overview Table 113. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 115. Sea-Bands Recent Development Table 116. Toulifly Company Information Table 117. Toulifly Business Overview Table 118. Toulifly Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 120. Toulifly Recent Development Table 121. Walgreens Company Information Table 122. Walgreens Business Overview Table 123. Walgreens Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 125. Walgreens Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Anti-Nausea and Vomiting Healthcare Device Distributors List Table 129. Anti-Nausea and Vomiting Healthcare Device Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Anti-Nausea and Vomiting Healthcare Device Product Image Figure 2. Global Anti-Nausea and Vomiting Healthcare Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-Nausea and Vomiting Healthcare Device Sales (2021-2032) & (K Units) Figure 5. Global Anti-Nausea and Vomiting Healthcare Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-Nausea and Vomiting Healthcare Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inhaler Image Figure 10. Wrist Band Image Figure 11. Food Image Figure 12. Others Image Figure 13. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Type (2021-2032) Figure 16. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type (2021-2032) Figure 19. For Children Image Figure 20. For Pregnant Image Figure 21. For other people with motion sickness Image Figure 22. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Application (2021-2032) Figure 25. Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application (2021-2032) Figure 28. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 33. North America Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 39. South America Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Anti-Nausea and Vomiting Healthcare Device Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Anti-Nausea and Vomiting Healthcare Device Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaler
  • Wrist Band
  • Food
  • Others
Applications
  • For Children
  • For Pregnant
  • For other people with motion sickness
Companies covered
  • Blisslets
  • Dramamine(Prestige Consumer Healthcare)
  • EmeTerm (WAT Medical)
  • GRAVOL
  • MotionCure (Sidis Labs)
  • NoMo
  • Psi Bands
  • Quease EASE (Soothing Scents)
  • Reliefband
  • Sea-Bands
  • Toulifly
  • Walgreens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  4. 1.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-Nausea and Vomiting Healthcare Device Market Dynamics
  1. 2.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
  2. 2.2 Anti-Nausea and Vomiting Healthcare Device Industry Drivers
  3. 2.3 Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges
  4. 2.4 Anti-Nausea and Vomiting Healthcare Device Industry Restraints
3 Anti-Nausea and Vomiting Healthcare Device Market by Company
  1. 3.1 Global Anti-Nausea and Vomiting Healthcare Device Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-Nausea and Vomiting Healthcare Device Average Price by Company (2021-2026)
  5. 3.5 Global Anti-Nausea and Vomiting Healthcare Device Company Ranking (2024-2026)
  6. 3.6 Global Anti-Nausea and Vomiting Healthcare Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-Nausea and Vomiting Healthcare Device Company Product Type and Application
  8. 3.8 Global Anti-Nausea and Vomiting Healthcare Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-Nausea and Vomiting Healthcare Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-Nausea and Vomiting Healthcare Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-Nausea and Vomiting Healthcare Device Market by Type
  1. 4.1 Anti-Nausea and Vomiting Healthcare Device Type Introduction
  2. 4.1.1 Inhaler
  3. 4.1.2 Wrist Band
  4. 4.1.3 Food
  5. 4.1.4 Others
  6. 4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type
  7. 4.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type
  11. 4.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Type (2021-2032)
  13. 4.3.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type (2021-2032)
5 Anti-Nausea and Vomiting Healthcare Device Market by Application
  1. 5.1 Anti-Nausea and Vomiting Healthcare Device Application Introduction
  2. 5.1.1 For Children
  3. 5.1.2 For Pregnant
  4. 5.1.3 For other people with motion sickness
  5. 5.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application
  6. 5.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application
  10. 5.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application (2021-2032)
6 Anti-Nausea and Vomiting Healthcare Device Regional Sales and Value Analysis
  1. 6.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032)
  5. 6.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-Nausea and Vomiting Healthcare Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  12. 6.6.2 North America Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  21. 6.9.2 South America Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Country, 2025 VS 2032
7 Anti-Nausea and Vomiting Healthcare Device Country-level Sales and Value Analysis
  1. 7.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032)
  6. 7.4 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-Nausea and Vomiting Healthcare Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Blisslets
  2. 8.1.1 Blisslets Company Information
  3. 8.1.2 Blisslets Business Overview
  4. 8.1.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  6. 8.1.5 Blisslets Recent Developments
  7. 8.2 Dramamine(Prestige Consumer Healthcare)
  8. 8.2.1 Dramamine(Prestige Consumer Healthcare) Company Information
  9. 8.2.2 Dramamine(Prestige Consumer Healthcare) Business Overview
  10. 8.2.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  12. 8.2.5 Dramamine(Prestige Consumer Healthcare) Recent Developments
  13. 8.3 EmeTerm (WAT Medical)
  14. 8.3.1 EmeTerm (WAT Medical) Company Information
  15. 8.3.2 EmeTerm (WAT Medical) Business Overview
  16. 8.3.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  18. 8.3.5 EmeTerm (WAT Medical) Recent Developments
  19. 8.4 GRAVOL
  20. 8.4.1 GRAVOL Company Information
  21. 8.4.2 GRAVOL Business Overview
  22. 8.4.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  24. 8.4.5 GRAVOL Recent Developments
  25. 8.5 MotionCure (Sidis Labs)
  26. 8.5.1 MotionCure (Sidis Labs) Company Information
  27. 8.5.2 MotionCure (Sidis Labs) Business Overview
  28. 8.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  30. 8.5.5 MotionCure (Sidis Labs) Recent Developments
  31. 8.6 NoMo
  32. 8.6.1 NoMo Company Information
  33. 8.6.2 NoMo Business Overview
  34. 8.6.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  36. 8.6.5 NoMo Recent Developments
  37. 8.7 Psi Bands
  38. 8.7.1 Psi Bands Company Information
  39. 8.7.2 Psi Bands Business Overview
  40. 8.7.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  42. 8.7.5 Psi Bands Recent Developments
  43. 8.8 Quease EASE (Soothing Scents)
  44. 8.8.1 Quease EASE (Soothing Scents) Company Information
  45. 8.8.2 Quease EASE (Soothing Scents) Business Overview
  46. 8.8.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  48. 8.8.5 Quease EASE (Soothing Scents) Recent Developments
  49. 8.9 Reliefband
  50. 8.9.1 Reliefband Company Information
  51. 8.9.2 Reliefband Business Overview
  52. 8.9.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  54. 8.9.5 Reliefband Recent Developments
  55. 8.10 Sea-Bands
  56. 8.10.1 Sea-Bands Company Information
  57. 8.10.2 Sea-Bands Business Overview
  58. 8.10.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  60. 8.10.5 Sea-Bands Recent Developments
  61. 8.11 Toulifly
  62. 8.11.1 Toulifly Company Information
  63. 8.11.2 Toulifly Business Overview
  64. 8.11.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  66. 8.11.5 Toulifly Recent Developments
  67. 8.12 Walgreens
  68. 8.12.1 Walgreens Company Information
  69. 8.12.2 Walgreens Business Overview
  70. 8.12.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  72. 8.12.5 Walgreens Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Nausea and Vomiting Healthcare Device Value Chain Analysis
  2. 9.1.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Nausea and Vomiting Healthcare Device Sales Mode & Process
  6. 9.2 Anti-Nausea and Vomiting Healthcare Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Nausea and Vomiting Healthcare Device Distributors
  9. 9.2.3 Anti-Nausea and Vomiting Healthcare Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst